Crossref
U.S. agency drops controversial changes to misconduct rules
Science · 2024
DOI: 10.1126/science.adt2251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2024. Verfasst von Jeffrey Mervis. Hauptthemen laut MEDLINE: Scientific Misconduct, United States Office of Research Integrity, Biomedical Research.
Abstract (Originalsprache)
In first regulatory overhaul in 20 years, Office of Research Integrity takes modest steps toward greater transparency
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Scientific MisconductUnited States Office of Research IntegrityBiomedical ResearchUnited States
Zitieren
APA
Mervis, J. (2024). U.S. agency drops controversial changes to misconduct rules. Science. https://doi.org/10.1126/science.adt2251
Vancouver
Mervis J. U.S. agency drops controversial changes to misconduct rules. Science. 2024. doi:10.1126/science.adt2251
BibTeX
@article{Mervis2024,
author = {Mervis, Jeffrey},
title = {U.S. agency drops controversial changes to misconduct rules},
journal = {Science},
year = {2024},
doi = {10.1126/science.adt2251}
}
EUVIMED